Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

306 results found

2017 ∙ WHO AFRO

Recommendation to replace PCV-10 by PCV-13 in routine immunization of children under the age of 12

  • Recommendation
  • Africa
  • Zambia
  • Pneumococcal disease
Download:
2017 ∙ IVAC

The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs)

  • Pneumococcal disease
Download:
2016 ∙ Saokaew, S. Rayanakorn, A. Wu, D. B. C. Chaiyakunapruk, N.

Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review

  • Newborn
  • Children
  • Adolescents
  • Low and Middle Income Countries
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Segal, N. Greenberg, D. Dagan, R. Ben-Shimol, S.

Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Ethical issues
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Gibson, E. Begum, N. Sigmundsson, B. Sackeyfio, A. Hackett, J. Rajaram, S.

Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review

  • All age groups
  • Influenza
  • Rotavirus
  • Meningococcal disease
  • Pneumococcal disease
  • Human papillomavirus (HPV)
  • Hepatitis B
  • Varicella
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Remschmidt, C. Harder, T. Wichmann, O. Bogdan, C. Falkenhorst, G.

Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: A systematic review

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2016 ∙ Diao, W. Q. Shen, N. Yu, P. X. Liu, B. B. He, B.

Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials

  • Adolescents
  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Schiffner-Rohe, J. Witt, A. Hemmerling, J. Von Eiff, C. Leverkus, F. W.

Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk - A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ DeAntonio, R. Yarzabal, J. P. Cruz, J. P. Schmidt, J. E. Kleijnen, J.

Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Puges, M. Biscay, P. Barnetche, T. Truchetet, M. E. Richez, C. Seneschal, J. Gensous, N. Lazaro, E. Duffau, P.

Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...